J. D. da Silva

Publications127
h-index28
Citations7,828
Highly Influential Citations311
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • D. M. van der Heijde
  • 835 Publications, 81,884 Citations
  • L. Gossec
  • 657 Publications, 22,646 Citations
  • T. Kvien
  • 829 Publications, 58,287 Citations
  • J. Smolen
  • 567 Publications, 42,949 Citations
  • Publications
  • Influence
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Recent insights in rheumatoid arthritis (RA) necessitated updating the European League Against Rheumatism (EULAR) RA management recommendations. A large international Task Force based decisions on… Expand
  • 1,747
  • 92
  • PDF
EULAR evidence-based recommendations for the management of fibromyalgia syndrome
Objective: To develop evidence-based recommendations for the management of fibromyalgia syndrome. Methods: A multidisciplinary task force was formed representing 11 European countries. The design of… Expand
  • 748
  • 31
  • PDF
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis
The objective was to develop evidence -based recommendations and a research and educational agenda for the non-pharmacological management of hip and knee osteoarthritis (OA). The multidisciplinary… Expand
  • 695
  • 28
  • PDF
Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.
CONTEXT Mesenchymal stem cells (MSCs) are under evaluation as a therapy for ischemic cardiomyopathy (ICM). Both autologous and allogeneic MSC therapies are possible; however, their safety and… Expand
  • 876
  • 24
  • PDF
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
A European League Against Rheumatism (EULAR) task force was established to define points to consider on use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Based on a… Expand
  • 383
  • 23
  • PDF
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data
Adverse effects of glucocorticoids have been abundantly reported. Published reports on low dose glucocorticoid treatment show that few of the commonly held beliefs about their incidence, prevalence,… Expand
  • 446
  • 11
Frequency and functional activity of Th17, Tc17 and other T-cell subsets in Systemic Lupus Erythematosus.
To compare frequency and functional activity of peripheral blood (PB) Th(c)17, Th(c)1 and Treg cells and the amount of type 2 cytokines mRNA we recruited SLE patients in active (n=15) and inactive… Expand
  • 78
  • 11
  • PDF
EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees.
It is the objective of the EULAR executive committee to promote actions and/or projects aimed at improving the knowledge and/or the recognition of musculoskeletal disorders. The chief aim is to… Expand
  • 199
  • 10
  • PDF
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology
In rheumatology and other medical specialties there is a discrepancy between the widespread use and the imprecise designation of glucocorticoid treatment regimens. Verbal descriptions of… Expand
  • 311
  • 8
  • PDF
European League Against Rheumatism recommendations for the inclusion of patient representatives in scientific projects
Objective To develop recommendations to enable successful inclusion of the patient perspective in European League Against Rheumatism (EULAR)-funded scientific research projects. Methods The EULAR… Expand
  • 174
  • 8
  • PDF